Skip to main content
SpringerLink
Log in

Systematic review: pneumonitis with PARP inhibitors

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ma Z, et al. Risk of pneumonitis in cancer patients treated with PARP inhibitors: A meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database. Gynecologic Oncology : 19 May 2021. Available from: URL: http://doi.org/10.1016/j.ygyno.2021.05.012

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systematic review: pneumonitis with PARP inhibitors. Reactions Weekly 1859, 10 (2021). https://doi.org/10.1007/s40278-021-97106-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-97106-2

Search

Navigation